scholarly journals Tumor-targeting, Systemically Delivered Antisense HER-2 Chemosensitizes Human Breast Cancer Xenografts Irrespective of HER-2 Levels

2002 ◽  
Vol 8 (8) ◽  
pp. 475-486 ◽  
Author(s):  
Antonina S. Rait ◽  
Kathleen F. Pirollo ◽  
Laiman Xiang ◽  
David Ulick ◽  
Esther H. Chang
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Tumor Targeting ◽  
Human Breast ◽  
Her 2 ◽  
Breast Cancer Xenografts

scholarly journals Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

Oncogene ◽  
1998 ◽  
Vol 17 (17) ◽  
pp. 2235-2249 ◽  
Author(s):  
Richard J Pietras ◽  
Mark D Pegram ◽  
Richard S Finn ◽  
Daniel A Maneval ◽  
Dennis J Slamon
Keyword(s):  
Breast Cancer ◽  
Monoclonal Antibody ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Humanized Monoclonal Antibody ◽  
Her 2 ◽  
Breast Cancer Xenografts

scholarly journals Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts

2009 ◽  
Vol 15 (20) ◽  
pp. 6358-6366 ◽  
Author(s):  
Giulio Francia ◽  
Shan Man ◽  
Chyan-Jang Lee ◽  
Christina R. Lee ◽  
Ping Xu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Her 2 ◽  
Breast Cancer Xenografts

Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu

2008 ◽  
Author(s):  
Ming-Chuan Hsu ◽  
Chee-Yin Chai ◽  
Ming-Feng Hou ◽  
Hui-Chiu Chang ◽  
Wan-Tzu Chen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Human Breast Cancer ◽  
Human Breast ◽  
Downstream Target ◽  
Her 2
Sign in / Sign up

Export Citation Format

Share Document